Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma · Metastatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Hani M. Babiker, MD)

Study leads

Hani M. Babiker, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

End of Life · Cancer

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Beijing, China